Loading...
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
BACKGROUND/AIMS: Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug interactions (DDIs) with DAAs might limit clinical prac...
Na minha lista:
| Udgivet i: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association for the Study of the Liver
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7820195/ https://ncbi.nlm.nih.gov/pubmed/33317251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0180 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|